SAB Biotherapeutics SABS
NASDAQ SABS
$2.88 -0.01 (-0.17%)
As of: Oct 21, 2026 · 2:35 PM EDT

SAB Biotherapeutics (SABS) Non-Current Debt (2020 - 2022)

Updated

SAB Biotherapeutics' Non-Current Debt came in at $541,644 for Q4 2022.

Analysis

SAB Biotherapeutics (SABS) Non-Current Debt (2020 - 2022) Analysis & Trends

  • Going back by year, Non-Current Debt was $172,037 in FY2020.
  • The Q4 2022 figure represents the lowest quarterly Non-Current Debt since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 37.34 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 62.48 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 23.83 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 60.50 Bn
10 SAB Biotherapeutics 228.89 Mn -188.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 541,644.00
Dec 31, 2021 1.80 Mn
Dec 31, 2020 882,805.00
API Access

SAB Biotherapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SABS&period=max&api_key=YOUR_API_KEY